Medite Cancer DiagnosticsMDIT 
$0.000.00%24h
0.00%24h
Global rank
Market cap$8.67K
Change 7d-
YTD Performance0.00%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of Medite Cancer Diagnostics (MDIT)
As of September 2024, Medite Cancer Diagnostics has a market cap of $8.67K. This makes Medite Cancer Diagnostics the world's th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Medite Cancer Diagnostics from 1995 to 2024
-
Value:-
Market cap history of Medite Cancer Diagnostics from 1995 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $8.67K | 0.00% |
| 2023 | $8.67K | -98.99% |
| 2022 | $858.56K | 4850.00% |
| 2021 | $17.34K | -96.83% |
| 2020 | $546.36K | -52.63% |
| 2019 | $1.15M | -33.50% |
| 2018 | $1.73M | -93.33% |
| 2017 | $26.02M | -41.18% |
| 2016 | $44.23M | -55.65% |
| 2015 | $99.73M | -61.79% |
| 2014 | $261.04M | 195.10% |
| 2013 | $88.46M | -32.00% |
| 2012 | $130.09M | -11.76% |
| 2011 | $147.43M | -32.00% |
| 2010 | $216.81M | -75.00% |
| 2009 | $867.24M | -86.67% |
| 2008 | $6.50B | -62.50% |
| 2007 | $17.34B | -53.49% |
| 2006 | $37.29B | 561.54% |
| 2005 | $5.64B | -18.75% |
| 2004 | $6.94B | -50.00% |
| 2003 | $13.88B | 0.00% |
| 2002 | $13.88B | -82.22% |
| 2001 | $78.05B | -10.89% |
| 2000 | $87.59B | 24.38% |
| 1999 | $70.42B | 160.26% |
| 1998 | $27.06B | 316.00% |
| 1997 | $6.50B | 50.00% |
| 1996 | $4.34B | -46.81% |
| 1995 | $8.15B | - |
MDIT Market Cap Today is $8.67K 0.00% - 26 Sept 2024
View largest stocks by market cap 
